Bvf Inc Cti Biopharma Corp Transaction History

Bvf Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$5.36 - $7.43 $625,345 - $866,850	-116,669 Reduced 1.31%	8,813,021 $51.3 Million
Q2 2021 Aug 16, 2021	BUY	$2.16 - $2.62 $4.32 Million - $5.24 Million	2,000,000 Added 28.86%	8,929,690 $22.3 Million
Q1 2018 May 07, 2018	SELL	$2.7 - $4.06 $4.5 Million - $6.77 Million	-1,666,667 Reduced 19.39%	6,929,690 $27 Million
Q3 2017 Nov 14, 2017	BUY	$3.12 - $3.65 $26.8 Million - $31.4 Million	8,596,357	8,596,357 $27.4 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.